Department for Science, Innovation and Technology written question – answered at on 20 November 2024.
What discussions he has had with the Medicines and Healthcare products Regulatory Agency on how to accelerate the acceptance of data generated in non-animal methods for drug safety decision making.
The Medicines and Healthcare products Regulatory Agency (MHRA) attended a ministerial roundtable on accelerating the adoption of alternatives to using animals for drug development earlier this year.
Yes1 person thinks so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.